Key questions concerning paracetamol and NSAIDs for osteoarthritis.
作者信息
Courtney P, Doherty M
机构信息
Academic Rheumatology, Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK.
出版信息
Ann Rheum Dis. 2002 Sep;61(9):767-73. doi: 10.1136/ard.61.9.767.
Abstract
摘要
相似文献
1
Key questions concerning paracetamol and NSAIDs for osteoarthritis.
Ann Rheum Dis. 2002 Sep;61(9):767-73. doi: 10.1136/ard.61.9.767.
2
The role of paracetamol in chronic pain: an evidence-based approach.
Am J Ther. 2005 Jan-Feb;12(1):80-91. doi: 10.1097/00045391-200501000-00011.
3
Trial of tramadol/acetaminophen tablets for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug.
J Rheumatol. 2005 Mar;32(3):568; author reply 568-9.
4
The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis.
Value Health. 2003 Mar-Apr;6(2):144-57. doi: 10.1046/j.1524-4733.2003.00215.x.
5
[Pharmacological therapies for osteoarthritis].
Therapie. 2011 Sep-Oct;66(5):383-90. doi: 10.2515/therapie/2011060. Epub 2011 Oct 27.
6
Acetaminophen for osteoarthritis.
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004257. doi: 10.1002/14651858.CD004257.pub2.
7
Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend?
Expert Opin Drug Saf. 2015 Aug;14(8):1259-68. doi: 10.1517/14740338.2015.1056776. Epub 2015 Jul 1.
8
Key questions concerning paracetamol and NSAIDs for OA.
Ann Rheum Dis. 2003 Mar;62(3):287; author reply 287. doi: 10.1136/ard.62.3.287.
9
The role of acetaminophen in the management of patients with osteoarthritis.
Am J Med. 2001 Feb 19;110 Suppl 3A:46S-9S. doi: 10.1016/s0002-9343(01)00618-0.
10
Managing osteoarthritis pain in the older population.
J Pain Palliat Care Pharmacother. 2013 Aug;27(3):292-5. doi: 10.3109/15360288.2013.817502. Epub 2013 Aug 2.
引用本文的文献
1
Model-Based Meta-Analysis Supporting the Combination of Acetaminophen and Topical Diclofenac in Acute Pain: A Therapy for Mild-to-Moderate Osteoarthritis Pain?
Pain Ther. 2024 Feb;13(1):145-159. doi: 10.1007/s40122-023-00569-z. Epub 2024 Jan 6.
2
Improvement of Pain Symptoms in Musculoskeletal Diseases After Multimodal Spa Therapy in the Austrian Gastein Valley-A Study Based on Longitudinal Registry Data.
Int J Public Health. 2023 Jun 8;68:1605931. doi: 10.3389/ijph.2023.1605931. eCollection 2023.
3
The Role of Medicinal and Aromatic Plants against Obesity and Arthritis: A Review.
Nutrients. 2022 Feb 25;14(5):985. doi: 10.3390/nu14050985.
4
Projected number of osteoarthritis patients in Austria for the next decades - quantifying the necessity of treatment and prevention strategies in Europe.
BMC Musculoskelet Disord. 2022 Feb 9;23(1):133. doi: 10.1186/s12891-022-05091-5.
5
The dangers of NSAIDs: look both ways.
Br J Gen Pract. 2016 Apr;66(645):172-3. doi: 10.3399/bjgp16X684433.
6
Paracetamol and analgesic nephropathy: Are you kidneying me?
Int Med Case Rep J. 2014 Dec 15;8:1-5. doi: 10.2147/IMCRJ.S71471. eCollection 2015.
7
Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial.
Knee Surg Sports Traumatol Arthrosc. 2014 Feb;22(2):345-50. doi: 10.1007/s00167-013-2408-0. Epub 2013 Jan 22.
8
An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
BMC Public Health. 2011 Nov 24;11:892. doi: 10.1186/1471-2458-11-892.
9
Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies.
Protoplasma. 2010 Oct;246(1-4):109-18. doi: 10.1007/s00709-010-0194-9. Epub 2010 Aug 19.
10
Perceived barriers to paracetamol (acetaminophen) prescribing, especially following rofecoxib withdrawal from the market.
Clin Rheumatol. 2009 May;28(5):509-19. doi: 10.1007/s10067-008-1077-8. Epub 2009 Jan 9.
本文引用的文献
1
A nurse-delivered advice intervention can reduce chronic non-steroidal anti-inflammatory drug use in general practice: a randomized controlled trial.
Rheumatology (Oxford). 2002 Jan;41(1):14-21. doi: 10.1093/rheumatology/41.1.14.
2
Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
JAMA. 2002 Jan 2;287(1):64-71. doi: 10.1001/jama.287.1.64.
3
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
JAMA. 2001 Nov 21;286(19):2398; author reply 2399-400.
4
A critique of the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis.
Arthritis Rheum. 2001 Oct;44(10):2451-5; author reply 2455-6. doi: 10.1002/1529-0131(200110)44:10<2451::aid-art416>3.0.co;2-f.
5
Use of acetaminophen in the treatment of osteoarthritis in patients with liver disease: comment on the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis.
Arthritis Rheum. 2001 Oct;44(10):2448-9; author reply 2455-6. doi: 10.1002/1529-0131(200110)44:10<2448::aid-art412>3.0.co;2-7.
6
Clinical implications of drug interactions with coxibs.
Pharmacotherapy. 2001 Oct;21(10):1223-32. doi: 10.1592/phco.21.15.1223.33891.
7
Risk of cardiovascular events associated with selective COX-2 inhibitors.
JAMA. 2001;286(8):954-9. doi: 10.1001/jama.286.8.954.
8
Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs.
Epidemiology. 2001 Sep;12(5):570-6. doi: 10.1097/00001648-200109000-00018.
9
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee.
Arthritis Rheum. 2001 Jul;44(7):1587-98. doi: 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X.
10
The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments.
Arthritis Rheum. 2001 Jul;44(7):1477-80. doi: 10.1002/1529-0131(200107)44:7<1477::AID-ART267>3.0.CO;2-O.
Zotero 插件